Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Decision of the Minister of Public Health: Banning of any Food Supplement Advertisement in the Mass Media

 
The Minister of Public Health Dr. Jamil Jabak issued a decision that bans all ads of food supplements on all audio-visual media and social media, under penalty of taking appropriate measures against those who violates the decision.
 
Article 1: Decision No.2207/1 of 18/12/2014 and 376/1 of 12/03/2019 on the regulation of the import of food supplements and energy drinks shall be amended and the following articles shall be added:
 
Article 2: the label of any food supplement should read the number and date of the license issued by the Ministry of Public Health to the manufacturer or importing company. This article shall come into effect three months after the publication of this decision.
 
Article 3: all ads of food supplements on all audio-visual media and social media are banned, under penalty of taking appropriate measures against those who violates the decision.
 
Article 4: this decision shall be communicated where needed.
    3
    ...
ATC Name B/G Ingredients Dosage Form Price
V03AC03 DEFIROX G Deferasirox - 500mg 500mg Tablet, dispersible L.L
L01BB04 MAVENCLAD B Cladribine - 10mg 10mg Tablet L.L
L01EB04 TAGRISSO B Osimertinib - 80mg 80mg Tablet, film coated L.L
L01EF02 KISQALI B Ribociclib - 200mg 200mg Tablet, film coated L.L
L01EC01 ZELBORAF B Vemurafenib - 240mg 240mg Tablet, film coated L.L
R03DX10 FASENRA B Benralizumab - 30mg 30mg Injectable solution L.L
L03AB11 PEGASYS BioTech Peginterferon alfa-2a - 180mcg/0.5ml 180mcg/0.5ml Injectable solution L.L
S01LA09 VABYSMO B Faricimab - 6mg/0.05ml 6mg/0.05ml Injectable solution L.L
L04AA36 OCREVUS BioTech Ocrelizumab - 300mg/10ml 300mg/10ml Injectable concentrate for solution L.L
B02BX06 HEMLIBRA BioTech Emicizumab - 60mg/0.4ml 60mg/0.4ml Injectable solution L.L
M09AX10 EVRYSDI B Risdiplam - 0.75mg/ml 0.75mg/ml Powder L.L
V03AC03 JADENU B Deferasirox - 360mg 360mg Tablet, film coated L.L
H01CB03 SOMATULINE AUTOGEL B Lanreotide (acetate) - 120mg 120mg Injectable solution L.L
L02AE04 DECAPEPTYL SR B Triptorelin (pamoate) - 3mg 3mg Injectable powder for suspension+diluent L.L
L01XK01 LYNPARZA B Olaparib - 150mg 150mg Tablet, film coated L.L
J06BA02 IMMUNOREL BioHuman Human normal immunoglobulin - 5g/100ml 5% Injectable solution L.L
L01FX14 POLIVY BioHuman Polatuzumab vedotin - 140mg 140mg Injectable powder for concentrate for solution L.L
L01EF01 PALBRANCE 125 G Palbociclib - 125mg 125mg Capsule L.L
L02BX03 ABLAX 500 G Abiraterone acetate - 500mg 500mg Tablet L.L
L02BX03 ABLAX 250 G Abiraterone acetate - 250mg 250mg Tablet L.L
L01EX08 LENVIMA B Lenvatinib - 4mg 4mg Capsule, hard L.L
L01EX08 LENVIMA B Lenvatinib - 10mg 10mg Capsule, hard L.L
L01EF01 PAPILLIO G Palbociclib - 100mg 100mg Capsule, hard L.L
L01FF03 IMFINZI BioTech Durvalumab - 500mg/10ml 500mg/10ml Injectable solution L.L
B02BX05 REVOLADE B Eltrombopag Olamine - 50mg 50mg Tablet, film coated L.L
L04AX04 REVLIMID B Lenalidomide - 10mg 10mg Capsule L.L
L01EA04 BOSULIF B Bosutinib - 500mg 500mg Tablet, film coated L.L
L01EA04 BOSULIF B Bosutinib - 400mg 400mg Tablet, film coated L.L
B02BX06 HEMLIBRA BioTech Emicizumab - 30mg/ml 30mg/ml Injectable solution L.L
L04AD02 PROGRAF 5MG B Tacrolimus - 5mg 5mg Capsule L.L
    3
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025